tiprankstipranks
pc:kriya

Kriya Therapeutics Inc

Morrisville, NC 27560, US
https://www.kriyatx.com/
Kriya Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing gene therapies for chronic diseases with high unmet medical needs. The company leverages its proprietary integrated manufacturing and R&D platform to create potentially transformative treatments in therapeutic areas such as ophthalmology, metabolic disease, and neurology. Kriya's pipeline includes gene therapies for conditions like Geographic Atrophy, Thyroid Eye Disease, Type 1 Diabetes, Metabolic Associated Steatohepatitis (MASH), and Trigeminal Neuralgia, aiming to set new standards for gene therapy purity, scale, and production cost.

Leadership & Board

Current Number of Employees193
Current LinkedIn Followers20,355

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$320M
Total Amount Raised$320M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$320M
Latest Funding Amount$320M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation
Post-Money Valuation

Employee Trend

Kriya Therapeutics Inc had 193 employees as of April 13, 2026. The number of employees increased by 1 (0.52%) week-over-week.
193Latest Employee Count
1(0.52%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Kriya Therapeutics Inc had 20,355 followers as of April 13, 2026. The number of followers increased by 55 (0.27%) week-over-week.
20,355Latest Followers Count
55(0.27%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 10, 2025
Series D
$320.00M

Investors

Related News and Analysis